Devana Solutions, LLC is one of the clinical research industry’s most innovative technology companies serving and partnering with the industry’s leading research organizations. This week we’re pleased to announce and introduce our latest partner-client: hyperCORE International – the second largest clinical research site organization in the world!

hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. hyperCORE International unifies the clinical research industry’s most respected and advanced research site companies, facilitating a level of unparalleled collaboration. hyperCORE International is an industry leader providing Phase I-IV clinical trial services with more than 81 active research sites across the globe. Its member companies have completed more than 6,000 studies helping to evaluate thousands of new drugs and treatments in more than 15,000,000 patients. Each member operates as an independent company but, through the sharing of best practices, hyperCORE International accelerates every aspect of the research site process – from feasibility through study start-up and completion. Its members have won numerous awards for performance, quality and innovation.

hyperCORE International partner members leveraging Devana Solutions, LLC flagship easy-to-use Devana IGNITE cloud software to simplify contact and account management, study start-up and execution, while seamlessly capturing performance metrics for analytics and reporting include: AGA Clinical Trials of Hialeah, Florida; Benchmark Research of Austin, Texas; Clinical Site Partners of Miami, Florida; Clinical Trials of Texas of San Antonio, Texas; DIEX Recherche of Sherbrooke, Canada; IACT Health of Columbus, Georgia; and LMC Manna Research of Toronto, Canada.

In another milestone for Devana Solutions, LLC, these member networks will operate Devana IGNITE in tandem with Devana PROPEL for hyperCORE International providing an operating system to support collaboration across the super network.

The future of clinical research is here. Devana Solutions, LLC, powering better data, better decisions and better outcomes.  #clinicalresearch #clinicaltrials #data #metrics #innovativetechnology

2019 was an explosive year of growth for Devana Solutions, LLC, one of the clinical trial industry’s most innovative technology companies, as many of the most recognizable names in the industry launched or expanded their use of the Devana Solutions platform for workflow management, and enhanced data capture and analysis to drive their continued success.

Among Devana’s prominent client-partners is Javara Research, a leading Integrated Research Organization spearheaded by seasoned clinical trials industry leaders including Jennifer Byrne, CEO, Amanda Wright, Vice President of Partnership Development, Susan Donahue, Director of Clinical Trial Operations, Drew Domescik, CFO and Linda McCarty, General Counsel & Privacy Officer. Tegan Mead, Associate Director of Healthcare Engagement – Privia Medical Group (Gulf Coast) rounds out the Javara leadership team who have collectively led over 10,000 trials and engaged more than 200,000 people in clinical trials. The use of advanced technologies like the Devana platform is central to Javara’s mission to make research more efficient and accessible.

In recent months, Javara has announced collaborations to increase patient-access to industry-sponsored, clinical trials with Wake Forest Baptist Medical Center, Tryon Medical Partners and Privia Health’s, Privia Medical Group – Gulf Coast and Georgia.  Javara will lead the effort to deliver clinical research as an innovative care offering to patients engaged with these leading healthcare organizations. Higher rates of clinical trial participation inside of a health system allows for improved access to cutting edge therapies, generating better outcomes and even lower care costs within patient-centered care helping to positively impact the landscape of medicine and healthcare.

Further evidence of Javara’s efforts to innovate and expand patient-access to clinical trials were announced last March when Javara announced the launch of Uber Health rides to lessen the burden for the 3.6 million Americans that miss medical appointments due to a lack of reliable transportation.

“We are truly humbled by the industry leading organizations that have chosen to leverage our Devana technology and Javara definitely epitomizes leadership and innovation in the clinical trials industry,” stated Devana Solutions’ CEO and Co-Founder, Barry Lake.

“Technology is transforming the way in which we conduct clinical research and business. The Devana Ignite for Sites solution allows us to transparently be in tune to our trials, activities and represents a centralized solution that supports the advancement of our business model,” said CEO of Javara, Jennifer Byrne. Javara is proud to lead paths forward that are transforming how clinical research is conducted with exceptional technologies to support.

About Javara, Inc.

Javara, Inc., an Integrated Research Organization (IRO), integrates with complex healthcare systems to ensure clinical research is available throughout the patient care cycle and positions the system to leverage clinical research as a population health strategy, while serving to support drug development needs as a clinical research site provider of high-quality study data. Together, Javara and its healthcare partners offer a more aligned, efficient, and effective solution to the challenges of patient inclusion in clinical trials, by creating an infrastructure where clinical research becomes an integral part of the state-of-the-art healthcare delivery offered by Javara’s healthcare partners. The Javara IRO platform offers better outcomes for patient-centered care, better economic results, easier access to cutting edge therapies for healthcare systems, and a more valuable and reliable research delivery model to the biopharmaceutical sector. For more information about Javara, Inc. visit: JavaraResearch.com.

About Devana Solutions, LLC

Devana Solutions, LLC is developer and provider of cloud-based SaaS technology driven by a core belief that data transparency through technology is critical to aligning the top performing research organizations at the investigative site level with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana offers technology to standardize operational workflows, particularly in study startup, across site functions while allowing for the automated capture, analysis and display of real time performance data across clinical trial industry stakeholders. For more information about Devana Solutions, LLC visit: www.DevanaSolutions.com.

(CHAPEL HILL, NC) – August 15, 2019 (last updated). In recent weeks many of you have heard me making the point that the clinical trial site industry needs more data so that ‘good’ sites can differentiate themselves from ‘bad’ sites.

It would be good for the sites – who will win more business – but more data would also allow CROs a greater ability to select sites that deliver effective clinical trials, ultimately making trials quicker and less costly.

Devana’s IGNITE and PROPEL technology allows important data to be stored and shared by clinical trial sites and site networks as the basis for a scorecard to demonstrate the strength of their performance and case for selection for a clinical trial.

I have often compared the Devana ‘Scorecard’ to the equivalent of a FICO score for the clinical trial site industry. The FICO score is now so commonplace, it struck me that many people do not know the story behind it, the impact it has had on consumer lending and what lessons it holds for the clinical trial site sector.

The FICO score allows banks, credit card companies and other lenders to evaluate the potential risk of lending money to consumers.

Before it existed, lending decisions were based partly on a report prepared on you in utmost secrecy and at the whim of the underwriter at the bank you were applying – apparently the report included such observations as the quality of your furniture and your character!

As ad-hoc and unreliable credit scoring systems were being developed by individual lenders, the FICO Score was developed in 1956 by the engineer William Fair and the mathematician Earl Isaac who had met while working at Stanford. They formed a company Fair, Isaac & Co (the initials of the company spell FICO – which is what the company re-named itself in 2009).

At first, the system was used by individual lenders as private clients of Fair Isaac. The first general purpose FICO score was developed in 1989. Fannie Mae and Freddie Mac began using it in 1995.

To underline how important the FICO score has become in consumer lending, more than 10 BILLION scores are purchased every year by lenders – and more than 100 million Americans have access to their own FICO score.

While the exact formula for calculating a score has never been revealed, we do know it includes weighted consideration of payment history, debt burden, length of credit history, types of credit and recent credit searches.

Just think how much risk has been taken out of lending thanks to the FICO Score.

And consumers, thanks to an amendment to the Fair Credit Reporting Act which passed in 2003, now get free access to their credit reports to gain an understanding of what they need to do to achieve a higher FICO Score to get cheaper loans.

It’s a win-win for both lenders and consumers.

And that’s exactly why we at Devana Solutions believe the clinical trials industry needs that FICO equivalent scorecard for sites and site networks.

The trial sites with good ‘credit’ will use the Devana Scorecard to prove it and win the business they deserve.

Trial sites whose ‘credit’ needs a little mending will know where they need to do to strengthen their game.

And the Sponsors and CROs will have a way of recruiting trial sites that greatly increases site performance predictability and improves clinical trial efficiency and effectiveness.

Another win-win!

About Devana Solutions, LLC

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs. www.devanasolutions.com

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

(Chapel Hill, NC) – April 13, 2019. The Association of Clinical Research Professionals (ACRP), a non-profit establishing industry standards for clinical research competence and workforce development, and Devana Solutions, provider of cloud-based metrics capture and data analytics software for clinical trial sites and networks, are excited to announce winners of the 2019 Annual Site Metrics Challenge Study. The study analyzed timing and performance metrics data and the impact of clinical site staff-training by accredited organizations such as ACRP, the leader in clinical trials workforce development and certification.

The study was headlined by three industry-leading Integrated Site Networks: IACT Health, a 17-site network throughout Georgia; LMC Manna Research, at 21 integrated sites across Canada; and PMG Research, Inc., ICON’s integrated site network covering 14 cities in the Mid-Atlantic & Midwest regions. Not surprisingly, each of the headlining site networks won in a category and ranked highly in the other metrics categories. Almost 200 investigative sites participated representing single-location research sites, site networks, highly-specialized sites and academic medical centers.

Participants submitted reports focused on five, specific study start-up and performance metrics which, along with a myriad of other data points, were already being automatically tracked and captured through their usage of Devana Solutions® IGNITE platform by the majority of participants.

Winners of the 2019 ACRP-Devana Solutions Site Metrics Challenge Study are:

Fastest Feasibility Turnaround
1st Place: LMC I Manna Research
2nd Place: MedPharmics

Fastest from Activation to First Screen
ForCare Clinical Research

Fastest Budget & Contract Turnaround Time
Winner in the Site Network Category: PMG Research, Inc.
Winner in the AMC Category: University of Sunshine Coast
Winner in the Specialty Site Category: Raleigh Neurology Associates Clinical Research

Contract Met Percentage
IACT Health

“We conceived of the ACRP-Devana Solutions Site Metrics Challenge Study to try to explore and test a thesis,” according to Jim Kremidas, Executive Director of ACRP, “That thesis being that strong site performance would highly correlate to sites and site networks that had a high commitment to ACRP site staffing, training, and development initiatives. We were pleased – but not surprised – to learn that all of the winning sites and site networks had a strong history and commitment to ACRP training and certification across a very high percentage of their site staff.”

“PMG Research is honored to be recognized for our efforts to decrease start up timelines. Making the clinical trials process more efficient benefits industry partners, sites, and patients by maximizing enrollment opportunity, contributing to faster data analysis, and improving time to market,” said Kathy Cole, Director of Feasibility at PMG Research.

“Devana’s technology facilitates more effective and efficient collaboration through a scalable and centralized platform, providing workflow automation, historical analysis, performance metrics, and custom live reporting from anywhere, any time,” said Simon Corman, Director, Business Development at LMC Manna Research.

“IACT Health has long been a proponent of adopting advanced technologies across our sites and of ACRP’s efforts around staffing, training and development,” stated Jeff Kingsley, CEO of IACT Health, “Clearly, both have contributed in supporting the performance of our dedicated team at IACT.”

ACRP and Devana Solutions believe that this year’s winners and participants will continue to raise the bar for clinical research. By recognizing these outstanding sites and celebrating their achievements, the organizations aim to inspire other high-performing sites to advance their education through ACRP’s training and certification and to improve performance through adopting the Devana IGNITE technology to capture and analyze site metrics toward the overall goal of making the Clinical Research Community stronger.

The ACRP – Devana Solutions First Annual Site Metrics Challenge Study winners will be recognized at the 2019 ACRP Annual Meeting Awards & Recognition Ceremony on April 12, 2019 in Nashville, Tennessee.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms, IGNITE, PROPEL and IQ for sponsors and cros, to provide historical and real-time data capture, aggregation and display to drug development stakeholders.

https://devanasolutions.com/

(Chapel Hill, NC) – January 7, 2019.  Devana Solutions® LLC, a software provider driven by a core belief that data transparency through technology is critical to align sites with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease, is pleased to announce its Sponsorship of the SCRS Global Oncology Site Solutions Summit in Austin.  The 2019 Global Oncology Site Solutions Summit takes place from February 2-3 at the Hilton, Austin in Texas. Devana Solutions will be exhibiting at Booth #7.

The Devana vision aligns well with the SCRS Oncology program vision: To cure cancer through efficiency in process and strength in the relationships between clinical research sites, pharmaceutical companies, and patients.  It is the Devana-SCRS shared belief that this conference will provide tremendous value to attendees and sponsors through partnerships between Sponsors, CROs and Sites.

Barry Lake, Devana’s CEO and Co-Founder stated, “Devana is committed to the success of the SCRS Global Oncology Summit. Our team enjoys seeing our clients, meeting new prospects and sharing our solution to enable sites to improve their operational performance and drive toward our shared goal of reducing drug development costs to deliver better outcomes for patients. Oncology is a key therapeutic area of focus for Devana and its partnership with SCRS continues to advance its goals and progress.”

“SCRS is pleased to include Devana Solutions as one of the innovative solution providers in our community.  Since its inception as a transformative innovator in our space, Devana – like so many others in our community — has contributed invaluable expertise and passion. Devana is a dedicated partner to research sites and SCRS.” commented Dawn Baron, Director of Strategic Initiatives for SCRS.

Devana Solutions team members will be on hand at Booth #7 to answer attendee questions and provide demonstrations of the Devana Solutions transformational software platform. Devana’s CEO will also be participating in a panel on Saturday, February 2, 2019 at 4:30 p.m. C.S.T. entitled “Budget Breakdown – Beyond Per-Patient Costs.”. The panel will be facilitated by Molly Downhour, Strategy Executive with Medix Clinical Research, another strategic partner of Devana Solutions, adding value to research sites and site networks.  To Register for this event, visit www.OncologySiteSolutionsSummit.com.

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com 

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com  (608) 285-2151

About SCRS

Founded in 2012, SCRS is a global trade organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,000 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, connectivity, and mentorship. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success.  Join the community. Visit mySCRS.org or register at www.OncologySiteSolutionsSummit.com

Contact: Sean Soth, sean.soth@myscrs.org (410) 963-2952

(Washington, DC) – December 17, 2018.   ACRP, a nonprofit that sets standards for clinical research competence has been working in collaboration with Devana Solutions (Devana) and industry-leading Site Networks on a study to analyze research site and network performance data based on workforce qualification.   Said Jim Kremidas, ACRP Executive Director, “In support of ACRP’s workforce development goals, we believe it is critical to analyze site staffing, training and development initiatives and their impact on performance. Since Devana Solutions’ IGNITE for sitessoftware helps sites capture key metrics for display and analysis, it is a natural fit to collaborate with them on this study.”  The Annual Metrics Challenge Study was launched in April at the ACRP Annual Conference and continues through April 12, 2019 when the next conference opens in Nashville. The results of the study will help gain insights into the impact of clinical trial training and development programs on trial site effectiveness.

Each site or site network participating in the Site Metrics Challenge Study, utilizes Devana Solutions’ IGNITE for sites platformfor more efficient study start-up and analytics on historic and current trial performance.  Devana Solutions’ IGNITE for sitesis a cloud-based platform allows sites to gather data in real time, analyze the results and decision against the analytics to drive process improvement and select more of the right trials from therapeutically and operationally-aligned industry Sponsors and CROs.  The first round of site performance metrics data was gathered from participating sites last month and will be collected and analyzed twice more before results of the study are revealed at ACRP Nashville in 2019.

The study is being headlined by key Research Networks –including LMC Manna I Research and IACT Health, with several other sites participating as well.  The study is open to any participating research sites who utilize Devana Solutions IGNITEfor sites technology platform

All participants are excited to be part of this ground-breaking work and shared some thoughts about the challenge.   Said Karri Venn, president of LMC Manna, “For over 20 years we have been on the forefront of clinical trial expertise and support the ARCP’s missing of improving efficiency and effectiveness of clinical trial management.   Given we were using the Devana platform, it was natural to work with the other top site networks to demonstrate each company’s efficiency and effectiveness for the good of the industry.” Added Felicia Irvin, VP Sales and Marketing of IACT Health “We stand behind the ACRP and its rigorous training; we pay for it and reward our employees for getting certified.  With the Devana Solutions overlay, we were in a position to help contribute to the ACRP Annual Metrics Challenge Study.”  Another participant of the challenge, Ashley Meinsenheimer from MedPharmics, saw the value of Devana Solutions’ IGNITE for sitesimmediately given her background in managing large datasets.  Meinsenheimer stated “I was pleased to participate in the ACRP challenge because it provided an opportunity for us to benchmark our site network against the best and it also provided an opportunity to demonstrate the usefulness of the technology to our employees.”

Barry Lake, Co-Founder and CEO of Devana stated “We are delighted to align with ACRP and our partner Site Networks to drive to excellence in clinical research through real time data and analytics.  Site performance data transparency to support the industry-leading trial sites and site networks is our sole focus at Devana.”

Full study results will be shared in the Spring of 2019 during the ACRP Annual Conference.

About ACRP

ACRP supports clinical research professionals through membership, training and development, and certification.  Founded in 1976, ACRP is a Washington, DC-based nonprofit organization with more than 13,000 members who work in clinical research in more than 70 countries. ACRP’s vision is that clinical research is performed ethically, responsibly, and professionally everywhere inthe world. ACRP’s mission is to promote excellence in clinical research.  www.acrpnet.org

Contact:  Jeremy Glunt, media@acrpnet.org(703) 258-3506

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites andPROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

(Chapel Hill, NC) – December 10, 2018.   Devana Solutions® LLC, makers of cloud-based performance data transparency software aimed at standardizing and improving Clinical Trial operations at the site level, today announced several new research partners utilizing its powerful IGNITE for sites technology.  These new clients represent single investigative sites, site networks, site management organizations (SMO), a leading integrated research organization, academic research centers, and span a wide range of therapeutic specialties.

“Our core mission is to provide technology to improve site processes and align the top research organizations with trial Sponsors which can dramatically cut trial cycle time, lower development costs and get therapeutic advances to patients faster” stated Barry Lake, CEO of Devana Solutions “That vision is rapidly becoming reality with our platform becoming the choice of the industry leaders in the research site space. We are truly humbled.”

The IGNITE for sites technology is a robust site metrics-capture and data analytics platform that delivers an industry leading solution for clinical trials management – from initial study lead through critical study start-up stages to patient screening and enrollment.  This allows for a more streamlined and efficient approach to clinical trial management – leading to faster cycle times and better outcomes – at lower costs.

Recent new clients being onboarded onto the Devana IGNITE for sitestechnology include:

• Cancer Treatment Centers of America (https://www.cancercenter.com/), a national network of five comprehensive cancer care and research centers and three outpatient centers serving cancer patients throughout the U.S.

• Raleigh Neurology Associates Clinical Research Center(http://www.raleighneurology.com/), a key player in the development and consequential approval of many cutting-edge treatment options for neurological conditions including MS, Parkinson’s and Alzheimer’s Disease with up to 100 clinical trials in all phases underway at any given time.

• University of Washington, Division of Cardiology(https://cardiology.uw.edu/about), with over 90 faculty at three hospitals and residence of the “Father of Exercise Cardiology”, Dr. Robert A. Bruce (deceased) who invented the multistage treadmill cardiac stress test in 1963 with the “Bruce Protocol” still taught in medical schools to this day.

• Javara Research(https://www.javararesearch.com/), a team of luminaries in clinical research who have collectively led over 10,000 trials and engaged more than 200,000 people in clinical trials with an innovative model of making clinical trials more accessible to patients by fully integrating industry-sponsored clinical trials into major health systems such as Wake Forest Baptist Medical Center.

• Elias Research Associates(https://www.eliasresearch.com/), a leading Study Management Organization (SMO) providing professional administrative and financial services to accelerate study start-up for specialists across the U.S. in almost every medical indication.

About Devana Solutions, LLC

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites andPROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com 

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

(Chapel Hill, NC) – December 10, 2018.   Devana Solutions® LLC, makers of cloud-based performance data transparency software aimed at standardizing and improving Clinical Trial operations at the site level, today announced several new research partners utilizing its powerful IGNITE for sites technology.  These new clients represent single investigative sites, site networks, site management organizations (SMO), a leading integrated research organization, academic research centers, and span a wide range of therapeutic specialties.

“Our core mission is to provide technology to improve site processes and align the top research organizations with trial Sponsors which can dramatically cut trial cycle time, lower development costs and get therapeutic advances to patients faster” stated Barry Lake, CEO of Devana Solutions “That vision is rapidly becoming reality with our platform becoming the choice of the industry leaders in the research site space. We are truly humbled.”

The IGNITE for sites technology is a robust site metrics-capture and data analytics platform that delivers an industry leading solution for clinical trials management – from initial study lead through critical study start-up stages to patient screening and enrollment.   This allows for a more streamlined and efficient approach to clinical trial management – leading to faster cycle times and better outcomes – at lower costs.

Recent new clients being onboarded onto the Devana IGNITE for sites technology include:

• Cancer Treatment Centers of America (https://beta.cancercenter.com/), a national network of five comprehensive cancer care and research centers and three outpatient centers serving cancer patients throughout the U.S.
• Raleigh Neurology Associates Clinical Research Center (http://www.raleighneurology.com/), a key player in the development and consequential approval of many cutting-edge treatment options for neurological conditions including MS, Parkinson’s and Alzheimer’s Disease with up to 100 clinical trials in all phases underway at any given time.
• University of Washington, Division of Cardiology (https://cardiology.uw.edu/about), with over 90 faculty at three hospitals and residence of the “Father of Exercise Cardiology”, Dr. Robert A. Bruce (deceased) who invented the multistage treadmill cardiac stress test in 1963 with the “Bruce Protocol” still taught in medical schools to this day.

• Javara Research (https://www.javararesearch.com/), a team of luminaries in clinical research who have collectively led over 10,000 trials and engaged more than 200,000 people in clinical trials with an innovative model of making clinical trials more accessible to patients by fully integrating industry-sponsored clinical trials into major health systems such as Wake Forest Baptist Medical Center.
• Elias Research Associates (https://www.eliasresearch.com/), a leading Study Management Organization (SMO) providing professional administrative and financial services to accelerate study start-up for specialists across the U.S. in almost every medical indication.About Devana Solutions, LLCDevana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com   

  Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com  (608) 285-2151

(CHAPEL HILL, NC) October 5, 2018 – Devana Solutions, LLC (“Devana”) is pleased to announce an integration of its robust data analytics and insights software Devana IGNITE for sites  and Real Time’s intuitive CTMS software to deliver an industry leading solution for research sites.   Clinical trials can now be seamlessly managed from initial study lead through the critical study start-up stages in Devana IGNITE to patient screening, enrollment and trial completion in RealTime-CTMS.   This integration will be available for demonstration at the upcoming SCRS – Site Solutions Summit in Boca Raton, Florida starting October 12, 2018.

The combined technologies allow for a more streamlined approach to collecting data by eliminating the need to input critical study information into separate systems.  Essentially, all data captured in either system is automatically transferred into and seamlessly displayed in the other platform.

“Devana’s IGNITE for sites robust start-up and analytics platform integrated with RealTime-CTMS is a winning combination for a complete end-to end solution for managing research site operations. This will give the top research sites and site networks a significant competitive advantage in reducing cycle time for their client  Sponsors and CROs” said Barry Lake, CEO of Devana.   Added Rick Greenfield, CEO of RealTime-CTMS, “We are very excited about this powerful integration. As leading software providers in our respective spaces, sites and site networks will now be able to leverage the power of both systems to streamline the flow of data, eliminate redundant data entry and make the management of business development, contact management, start-up activities, study execution and performance metrics easier and faster.”

For a limited time, current and new customers will receive a discount on the integrated software.   Research site customers of both companies are encouraged to contact their Devana Solutions or RealTime representatives for more information or a demonstration.

Both companies are building upon their long-standing commitment to meet customer needs and develop innovative solutions to empower investigative sites to conduct the world’s best research.

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs. To learn more visit https://devanasolutions.com

CONTACT:

Matt Smith, Executive Director, Strategic Partnerships

msmith@devanasolutions.com

(608) 285-2151

About RealTime-CTMS:

RealTime-CTMS is designed to provide quick and easy access to study or subject information utilizing simple and intuitive navigation.   In most cases, needed information is only a few clicks away.  RealTime- stakeholders. To learn more visit https://realtime-ctms.com

CONTACT:

Rick Greenfield, CEO

rgreenfield@realtime-ctms.com

(210) 852-4310